Nexentis Technologies宣布Mitocarex与Boltz达成合作,共同推进AI驱动的SLC小分子药物发现

美股速递
Jun 22

Nexentis Technologies Inc宣布,其旗下Mitocarex部门已与Boltz公司达成合作,将共同利用人工智能技术推进SLC(溶质载体)小分子药物的发现工作。此次合作旨在结合双方在生物技术与人工智能算法领域的专长,加速针对SLC靶点的新药研发进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10